Reviva Pharmaceuticals Holdings Stock Price on October 9, 2024

RVPHW Stock  USD 0.15  0.01  7.14%   
If you're considering investing in Reviva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Reviva Pharmaceuticals stands at 0.15, as last reported on the 19th of December, with the highest price reaching 0.17 and the lowest price hitting 0.12 during the day. Reviva Pharmaceuticals is out of control given 3 months investment horizon. Reviva Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.12, which implies the firm had a 0.12% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.68% are justified by taking the suggested risk. Use Reviva Pharmaceuticals Coefficient Of Variation of 859.86, semi deviation of 17.48, and Risk Adjusted Performance of 0.102 to evaluate company specific risk that cannot be diversified away.
  
Reviva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1163

Best PortfolioBest Equity
Good ReturnsRVPHW
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 23.06
  actual daily
96
96% of assets are less volatile

Expected Return

 2.68
  actual daily
53
53% of assets have lower returns

Risk-Adjusted Return

 0.12
  actual daily
9
91% of assets perform better
Based on monthly moving average Reviva Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Reviva Pharmaceuticals by adding it to a well-diversified portfolio.

Reviva Pharmaceuticals Valuation on October 9, 2024

It is possible to determine the worth of Reviva Pharmaceuticals on a given historical date. On October 9, 2024 Reviva was worth 0.11 at the beginning of the trading date compared to the closed value of 0.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Reviva Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Reviva Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Reviva Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Reviva Pharmaceuticals' related companies.
 Open High Low Close Volume
  0.10    0.12    0.08    0.11    9,980  
10/09/2024
  0.11    0.11    0.11    0.11    301.00  
  0.11    0.11    0.11    0.11    8,187  
Backtest Reviva Pharmaceuticals  |  Reviva Pharmaceuticals History  |  Reviva Pharmaceuticals Valuation   PreviousNext  
Open Value
0.11
0.11
Closing Value
69.30
Upside

Reviva Pharmaceuticals Trading Date Momentum on October 9, 2024

On October 10 2024 Reviva Pharmaceuticals Holdings was traded for  0.11  at the closing time. The highest daily price throughout the period was 0.11  and the lowest price was  0.11 . The daily volume was 8.2 K. The net trading volume on 10/10/2024 did not cause price change. The trading delta at closing time to current closing price is 27.27% .

Reviva Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Reviva Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Reviva financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Reviva Pharmaceuticals Stock history

Reviva Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Reviva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Reviva Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Reviva Pharmaceuticals stock prices may prove useful in developing a viable investing in Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. Reviva Pharmaceuticals is traded on NASDAQ Exchange in the United States.

Reviva Pharmaceuticals Stock Technical Analysis

Reviva Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Reviva Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Reviva Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Reviva Pharmaceuticals Period Price Range

Low
December 19, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Reviva Pharmaceuticals Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Reviva Pharmaceuticals December 19, 2024 Market Strength

Market strength indicators help investors to evaluate how Reviva Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reviva Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reviva Pharmaceuticals stock market strength indicators, traders can identify Reviva Pharmaceuticals Holdings entry and exit signals to maximize returns

Reviva Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Reviva Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Reviva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Reviva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.